Like most non-enterprise and agile biopharmaceutical companies, Arvinas does not have a large IT team and does not desire heavy IT infrastructure. To meet the ever growing demand of simplifying deployment and maintenance of solutions, D360 was implemented and hosted in the cloud. They have increased the number of data sources and complexity of data, which are now seamlessly integrated with D360 providing complete transparency to their end users. They currently have approximately 70 scientists using D360, running over 700 distinct D360 queries.

We need to be able to query, pivot and dive deep into our drug discovery data, and D360 is the best platform we have found for that. Compared to our previous research informatics solution, D360 is saving us hundreds of hours annually on data analysis. That is an important contribution to our research. The Certara team is tenacious and resourceful. They always find a solution. That’s what has made our relationship so successful.

Dr. Keith Hornberger Director of Chemistry Arvinas

Arvinas is the pioneer and clinical-stage leader in the exciting, new area of targeted protein degradation. Its proprietary PROTAC® (proteolysis-targeting chimera) protein degraders are chimeric, modular small molecules, which harness the body’s natural protein disposal system, the ubiquitin‐proteasome system, to induce the degradation of disease‐causing proteins. Arvinas’ current drug discovery focus areas include metastatic prostate cancer, locally-advanced or metastatic breast cancer, and neurodegenerative diseases.

About D360
D360™(ディー・スリーシックスティ)は製薬業界を代表する科学データ専用のインフォマティクスプラットフォームです。現在、低分子化合物や生物学的製剤の創薬研究に携わる世界各国の 6,000 名を超える研究者に活用されています。従来であれば IT 部門の支援無しでは難しかった各データに対するアクセスを研究者主導で簡単に進めることができるだけでなく、解析や可視化も同一環境上で即座に実施することができます。To learn more, visit www.certara.com/d360

お手伝いできることはありませんか?

サターラにお問合せください。お客様のプロジェクトを迅速に推し進める方法を一緒に考えませんか。

トップに戻る
Powered by Translations.com GlobalLink OneLink Software